PSNL Personalis, Inc.

BEARISH Impact: 5/10 144
Horizon weeks Filed May 28, 2026 Processed 8d 4h ago SEC 0001950047-26-005239
Form 144 — notice of proposed sale of securities

Price Chart

Loading chart...

Executive Summary

Director and Officer Christopher M. Hall filed a Form 144 notice of intent to sell 100,000 shares of Personalis common stock, with an approximate market value of $949,000 based on the filing date. The shares derive from stock option exercises expected over the next three months. While this represents a notable insider sale, it is structured as a planned exercise-and-sell program of options, not a discretionary open-market sale, which slightly reduces the negative signal.

Actionable Insight

A director/officer filing to sell a meaningful but not massive block (~0.1% of market cap) through option-exercise-sales scheduled over three months. This is not an emergency liquidation but may signal the insider's view that current price levels are acceptable to monetize. Monitor for the actual Form 4 filings on execution to see if the pace accelerates. The stock has historically reacted negatively to prior reports on this ticker; context suggests a slight bearish bias near-term.

Key Facts

  • Filer: Christopher M. Hall (Director and Officer of Personalis, Inc.)
  • Proposed sale of 100,000 shares of common stock
  • Estimated aggregate market value: $949,000 (based on ~$9.49/sh at filing)
  • Shares to be acquired through exercise of stock options over next three months
  • Filing date: May 28, 2026
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Market cap of issuer: ~$994M (proposed sale ~0.095% of market cap)

Financial Impact

Proposed sale of 100,000 shares valued at ~$949,000, representing ~0.1% of issuer's market cap.

dilution

Risk Factors

  • Insider may proceed with full sale over three months, adding supply-side pressure
  • The structured option exercise program could indicate planned diversification rather than outlook-driven selling, but the intent remains a negative signal
  • Stock's market cap ~$994M means this sale size is modest but could still weigh on sentiment given ticker's recent poor call performance

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005239
Document: 0001950047-26-005239-index.html0001950047-26-005239
Document: 0001950047-26-005239.txt0001950047-26-005239
5 reports for PSNL
Performance horizon
Filters
Rows
Reports for PSNL — sortable, filterable
Type Now
Jun 6, 2026
today
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+20
Jun 4, 2026
1d ago
144
NEUTRAL ★ 3/10
$12.08 awaiting T+20awaiting T+20$10.75 (−11.01%)
May 30, 2026
7d ago
Insider Cluster
BEARISH ★ 5/10
awaiting T+20
May 29, 2026
7d ago
144
NEUTRAL ★ 3/10
awaiting T+20
May 28, 2026
8d ago
144
BEARISH ★ 5/10
awaiting T+20
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (36h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access